Filtered By:
Condition: Atrial Fibrillation
Infectious Disease: COVID-19
Countries: China Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study.
CONCLUSION: The CHA2DS2-VASc score predicted in-hospital mortality in patients with COVID-19, regardless of AFib. PMID: 33034573 [PubMed - as supplied by publisher]
Source: Turk Kardiyoloji Dernegi arsivi - October 1, 2020 Category: Cardiology Authors: Quisi A, Alıcı G, Harbalıoğlu H, Genç Ö, Er F, Allahverdiyev S, Yıldırım A, Kurt IH Tags: Turk Kardiyol Dern Ars Source Type: research

Medtech in a Minute: Feeling the Coronavirus Pinch, J & amp;J & #039;s Apple Study, and More
Coronavirus Hurts Big Medtech's Bottom Line  As the Chinese healthcare system focuses on containing the spread of the coronavirus, medical device companies doing business in China are seeing lower procedure volumes, which means lower-than-expected revenue in the first quarter. Boston Scientific, for example, expects the virus to lower first-quarter revenue by $10 million to $40 million.   J&J and Apple Have Big Hopes for Heartline Study Johnson & Johnson’s Janssen Pharmaceutical unit and Apple opened enrollment for the Heartline Study, which aims to ...
Source: MDDI - March 2, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news